Sci Transl Med:伤口愈合,只需不到60秒?

2017-10-10 佚名 “中国生物技术网”微信号

一种有弹性带粘性的外科黏合凝胶将给抢救治疗带来革命性的变化,它能够在几秒钟内封闭严重的伤口。

一种有弹性带粘性的外科黏合凝胶将给抢救治疗带来革命性的变化,它能够在几秒钟内封闭严重的伤口。

澳大利亚和美国的科学家合作开发出了这种能够救命的外科黏合凝胶,将其命名为MeTro。其实科学家们并不是第一次考虑开发这种东西,但是问题在于,这些外科黏合凝胶与人类组织相互排斥。MeTro的重要创新在于它的弹性,它是一种混合弹性蛋白,非常适合为持续扩张和放松的身体组织“打补丁”,比如肺、心脏和动脉。这项研究发表在近日的《Science Translational Medicine》上。

MeTro可以直接作用于内部或外部的伤口。

美国东北大学的Nasim Annabi是研究团队成员之一,他说:“MeTro配方的优点在于,只要将其接触组织表面,它就会凝固成凝胶状态。”之后,使用紫外线照射MeTro,使其密封住。这种治疗伤口的方法比如缝针等传统治疗方法快两倍。

Annabi补充说:“我们在现场治疗的时候使用光调节交联疗法进一步使其固定。密封剂可以被非常精确地放置,并紧密地与组织表面的结构绑定。”

悉尼大学教授Anthony Weiss将MeTro类比成浴室和厨房磁砖使用的硅酮密封胶。但是与硅酮密封胶不同的是,MeTro的降解过程没有毒性。MeTro中含有一种降解酶,它能够决定MeTro分解的时间,从而使伤口可以愈合。

Weiss说:“MeTro像液体一样,可以填平缝隙,兼容于伤口的形状。它的生物反应很好,可以与人体组织紧密地对接,从而促进治疗。而且,MeTro还很容易存储,可以直接喷涂于伤口。”

目前为止,这项技术只用于动物试验,暂时还没有安排人类试验。MeTro已成功地治疗了小鼠的动脉和肺部切口,以及猪的肺部切口,这些伤口都需要得到及时的治疗。考虑到该技术的潜力已经得到证明,研究人员对于人类试验非常乐观。

Weiss说:“我们证明,MeTro在多种环境中都起作用,可以解决其他黏合剂解决不了问题。我们正在计划进行人体试验,希望MeTro可以很快被用于临床,拯救人类的生命。”

原始出处:

Annabi, N., et al., Engineering a highly elastic human protein-based sealant for surgical applications. Sci Transl Med, 2017. 9(410).

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1656889, encodeId=82e616568890c, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Wed Oct 25 18:19:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067284, encodeId=413a206e28462, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Fri Aug 10 03:19:00 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309863, encodeId=67bf13098639b, content=<a href='/topic/show?id=5e6926003ae' target=_blank style='color:#2F92EE;'>#伤口愈合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26003, encryptionId=5e6926003ae, topicName=伤口愈合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Thu Oct 12 06:19:00 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608102, encodeId=4f9b16081020b, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Oct 12 06:19:00 CST 2017, time=2017-10-12, status=1, ipAttribution=)]
    2017-10-25 bsmagic9140
  2. [GetPortalCommentsPageByObjectIdResponse(id=1656889, encodeId=82e616568890c, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Wed Oct 25 18:19:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067284, encodeId=413a206e28462, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Fri Aug 10 03:19:00 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309863, encodeId=67bf13098639b, content=<a href='/topic/show?id=5e6926003ae' target=_blank style='color:#2F92EE;'>#伤口愈合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26003, encryptionId=5e6926003ae, topicName=伤口愈合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Thu Oct 12 06:19:00 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608102, encodeId=4f9b16081020b, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Oct 12 06:19:00 CST 2017, time=2017-10-12, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1656889, encodeId=82e616568890c, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Wed Oct 25 18:19:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067284, encodeId=413a206e28462, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Fri Aug 10 03:19:00 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309863, encodeId=67bf13098639b, content=<a href='/topic/show?id=5e6926003ae' target=_blank style='color:#2F92EE;'>#伤口愈合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26003, encryptionId=5e6926003ae, topicName=伤口愈合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Thu Oct 12 06:19:00 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608102, encodeId=4f9b16081020b, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Oct 12 06:19:00 CST 2017, time=2017-10-12, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1656889, encodeId=82e616568890c, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Wed Oct 25 18:19:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067284, encodeId=413a206e28462, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Fri Aug 10 03:19:00 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309863, encodeId=67bf13098639b, content=<a href='/topic/show?id=5e6926003ae' target=_blank style='color:#2F92EE;'>#伤口愈合#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26003, encryptionId=5e6926003ae, topicName=伤口愈合)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Thu Oct 12 06:19:00 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1608102, encodeId=4f9b16081020b, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Oct 12 06:19:00 CST 2017, time=2017-10-12, status=1, ipAttribution=)]

相关资讯

Science:伤口愈合会留疤痕可怎么办?看这里!

科学家们最近找到一种让伤口愈合为再生皮肤而非疤痕组织的新方法,这种方法可以将伤口处最常见的细胞类型转变成脂肪细胞,在该研究之前一直认为这种转变在人体上不可能发生。相关研究结果发表在国际学术期刊Science上。 在正常情况下皮肤中有脂肪细胞存在,但是当伤口愈合为疤痕脂肪细胞就会消失。肌成纤维细胞是处于愈合过程的伤口中最常见的一类细胞,被认为只能形成疤痕组织。疤痕组织中也没有任何毛囊因此看起来

Nat Commun:改善伤口愈合的新靶点

MicroRNA是新的治疗剂的有趣靶标结构。它们可以通过合成抗氧化剂阻断。然而,到目前为止,仅在局部使用这些数据是不可能的。歌德大学法兰克福的研究人员现在已经成功地实现了这一点,在光诱导型抗生素的帮助下治疗伤口愈合受损。

Adv Sci:磁性阴阳微马达光热“焊接”促进组织伤口愈合

利用光热引发的高温能够降低伤口术后感染的风险,是一种悠久的消炎杀菌方法。近年来,借助光热方法与纳米技术的结合来治疗组织伤口的研究日益增多。光热疗法对愈合有机体的组织损伤具有积极作用,相对于传统的手术缝合、纳米粒子交联等方法,激光治疗具有治疗时间短、组织伤口闭合快、细菌等引起伤口感染的风险小等特点。采用近红外激光辐照组织伤口能够有效促进患处组织细胞新陈代谢,从而加快伤口愈合。基于聚电解质多层膜的微纳

Toxicol Sci:重金属镉通过影响受伤后炎症反应干扰皮肤伤口愈合

镉是人体非必需元素,在自然界中常以化合物状态存在,正常环境状态下不会影响人体健康,但是它比其它重金属更容易被农作物所吸附。镉被广泛应用于电镀工业、电子业和核工业等领域。相当数量的镉通过废气、废水、废渣排入环境,造成污染。当环境受到镉污染后,可在生物体内富集,通过食物链进入人体引起慢性中毒。

J Periodontol:自体富血小板纤维蛋白膜在龈沟液中生长因子水平与牙周愈合中的优势

本研究评估血小板富集纤维蛋白(PRF)与常规瓣膜手术联合对龈沟液(GCF)和牙周愈合中生长因子水平的影响。

ACS Appl Mater Interfaces:新型纳米涂层可有效加速伤口愈合

具有细胞外基质(ECM)衍生生物分子的表面仿生改性是加速血管支架病变愈合的新兴潜力的方法。然而,构建的生物功能层在维持其长期效率和预防血栓和新生血管内膜增生方面的能力不足仍然是临床应用的主要限制。在ECM的结构和功能的基础上,研究人员在316L不锈钢(SS)表面上构建了一种新型的基质细胞衍生因子-1α(SDF-1α)/层粘连蛋白负载纳米涂层,以提高调节血管重塑的功能。修饰后的表面可以控制生物分子的